When conducting due diligence for a life sciences company, it's essential to align the scope with the transaction's objectives. Key considerations include:

• Transaction Purpose: Determine if the goal is asset divestiture, strategic acquisition, or another objective.
• Regulatory Compliance: Assess adherence to industry regulations, including FDA guidelines and privacy laws.
• Operational Areas: Evaluate critical functions such as sales, marketing, and manufacturing processes.
• Risk Assessment: Identify potential issues like FDA warning letters or compliance violations.

Tailoring the due diligence process to these factors ensures a comprehensive evaluation, balancing thoroughness with cost-effectiveness. For more detailed guidance, reach out to us.

Support the show